OpenLegislation

Schedule THE ENTRIES INSERTED IN SCHEDULE 1 TO THE PRINCIPAL ORDER

Original text. Later amendments are not shown.

Column 1Column 2Column 3Column 4Column 5
SubstanceMaximum strengthRoute of administration, use or pharmaceutical formTreatment limitationsMaximum quantity
Aloxiprin
(1)

620 mg

(1)

Non-effervescent tablets and capsules

(1)

The quantity sold or supplied in one container or package shall not exceed 32

  • The quantity of non-effervescent tablets, capsules or a combination of both sold or supplied to a person at any one time shall not exceed 100

(2)

All preparations other than non-effervescent tablets or capsules

Diphenhydramine HydrochlorideAll preparations except liquid-filled capsules
Hydrocyanic Acid
Ibuprofen LysineRheumatic and muscular pain, pain of non-serious arthritic conditions, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza
Internal
(a)

In the case of a prolonged release preparation 600 mg (MD) 1,200 mg (MDD)

(b)

in any other case 400 mg (MD) 1,200 mg (MDD)

Levocabastine HydrochlorideEquivalent of 0.05 per cent Levocabastine
(1)

Nasal sprays

For the symptomatic treatment of seasonal allergic rhinitis

(1)

Container or package containing not more than 10 ml of medicinal product

(2)

Aqueous eye drops

For the symptomatic treatment of seasonal allergic conjunctivitis

(2)

Container or package containing not more than 4 ml of medicinal product

Nilutamide
PhytomenadioneAny use except the prevention or treatment of haemorrhagic disorders
Strychnine Nitrate
Sulfabenzamide